The National Institutes of Health (NIH) defines a Clinical Trial as a research study in which one or more human subjects are prospectively assigned to one or more interventions. Clinical trials help develop novel drugs (Investigational Products) by providing early access to patients who volunteer to participate in the research study.
BioCytics and our expert Providers participate in both Interventional (administration of a drug or device) and Observational (characterization of a patient group) clinical trials listed below. The eligibility criteria described in the trial information enables patients with advanced solid tumors to access these Investigational Products. In addition to sponsoring our own clinical trial, BioCytics also participates in externally sponsored biopharma trials. Please view the list of trials below that are currently enrolling patients: